Similar articles

• The response of mice infected with T. brucei to the administration of sheep erythrocytes.

  Murray PK, Urquhart GM, Murray M, Jennings FW. Murray PK, et al. Trans R Soc Trop Med Hyg. 1973;67(2):267. doi: 10.1016/0035-9203(73)90173-9. Trans R Soc Trop Med Hyg. 1973. PMID: 4544657 No abstract available.
• The nature of immunosuppression in Trypanosoma brucei infections in mice. II. The role of the T and B lymphocytes.

  Murray PK, Jennings FW, Murray M, Urquhart GM. Murray PK, et al. Immunology. 1974 Nov;27(5):825-40. Immunology. 1974. PMID: 4548043 Free PMC article.
• B lymphocytes of mice display an aberrant activation phenotype and are cell cycle arrested in G0/G1A during acute infection with Trypanosoma brucei.

  Sacco RE, Hagen M, Donelson JE, Lynch RG. Sacco RE, et al. J Immunol. 1994 Aug 15;153(4):1714-23. J Immunol. 1994. PMID: 7519210
• Hematologic manifestations, diagnosis, and immunopathology of African trypanosomiasis.

  Wéry M, Mulumba PM, Lambert PH, Kazyumba L. Wéry M, et al. Semin Hematol. 1982 Apr;19(2):83-92. Semin Hematol. 1982. PMID: 7041266 Review. No abstract available.
• Trypanosoma brucei genomics and the challenge of identifying drug and vaccine targets.

  Agbo EC, Majiwa PA, Büscher P, Claassen E, te Pas MF. Agbo EC, et al. Trends Microbiol. 2003 Jul;11(7):322-9. doi: 10.1016/s0966-842x(03)00151-3. Trends Microbiol. 2003. PMID: 12875816 Review. No abstract available.